{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:08:15Z","timestamp":1763993295408,"version":"3.45.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Geriatric Clinical Medicine Research Center of Sichuan Province","award":["23LHHGYSD30"],"award-info":[{"award-number":["23LHHGYSD30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25476-5","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:31:18Z","timestamp":1763987478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value assessment and in vitro validation of mitochondria-ferroptosis-related genes in multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"25476_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk, N., Pawlyn, C. & Yong, K. L. Multiple myeloma. Lancet 397, 410\u2013427 (2021).","journal-title":"Lancet"},{"key":"25476_CR2","doi-asserted-by":"crossref","unstructured":"Zhang, W., Liu, Y., Liao, Y., Zhu, C. & Zou, Z. GPX4, ferroptosis, and Diseases Vol. 174, 116512 (Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, 2024).","DOI":"10.1016\/j.biopha.2024.116512"},{"key":"25476_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.chembiol.2020.03.016","volume":"27","author":"A Belavgeni","year":"2020","unstructured":"Belavgeni, A., Meyer, C., Stumpf, J., Hugo, C. & Linkermann, A. Ferroptosis and necroptosis in the kidney. Cell. Chem. Biol. 27, 448\u2013462 (2020).","journal-title":"Cell. Chem. Biol."},{"key":"25476_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"XJ Jiang","year":"2021","unstructured":"Jiang, X. J., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell. Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"25476_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.chembiol.2020.03.007","volume":"27","author":"RR Ratan","year":"2020","unstructured":"Ratan, R. R. The chemical biology of ferroptosis in the central nervous system. Cell. Chem. Biol. 27, 479\u2013498 (2020).","journal-title":"Cell. Chem. Biol."},{"key":"25476_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell, B. R., Jiang, X. J. & Gu, W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell. Biol. 30, 478\u2013490 (2020).","journal-title":"Trends Cell. Biol."},{"key":"25476_CR7","doi-asserted-by":"crossref","unstructured":"Douglas, R. & Bernadette, V. G. The pantheon of the fallen: why are there so many forms of cell death? Trends Cell. Biol. 22, 555\u2013556 (2012).","DOI":"10.1016\/j.tcb.2012.08.008"},{"key":"25476_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/imr.12533","volume":"277","author":"SJ Dixon","year":"2017","unstructured":"Dixon, S. J. Ferroptosis: bug or feature? Immunol. Rev. 277, 150\u2013157 (2017).","journal-title":"Immunol. Rev."},{"key":"25476_CR9","doi-asserted-by":"crossref","unstructured":"Howard, O., Peter, F. & Tom, V. B. V. How do we fit ferroptosis in the family of regulated cell death? Cell. Death Differ. 24, 1991\u20131998 (2017).","DOI":"10.1038\/cdd.2017.149"},{"key":"25476_CR10","first-page":"26","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia, A. M. et al. Ferroptosis and cancer: mitochondria Meet the iron maiden. Cell. Death Cells. 9, 26 (2020).","journal-title":"Cell. Death Cells"},{"key":"25476_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejcb.2019.151058","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang, H., Liu, C., Zhao, Y. X. & Gao, G. Mitochondria regulation in ferroptosis. Eur. J. Cell. Biol. 99, 11 (2020).","journal-title":"Eur. J. Cell. Biol."},{"key":"25476_CR12","doi-asserted-by":"crossref","unstructured":"Joe, D. D., Aj, L., Xuezhi, A. & Thierry, S. Z. Reactive oxygen species and mitochondria: A nexus of cellular homeostasis. Redox Biol. 6, 472\u2013485 (2015).","DOI":"10.1016\/j.redox.2015.09.005"},{"key":"25476_CR13","doi-asserted-by":"crossref","unstructured":"Oliver, S. & Roland, L. The role of mitochondria in cellular iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. Cold Spring Harb Perspect. Biol. 5, a011312 (2013).","DOI":"10.1101\/cshperspect.a011312"},{"key":"25476_CR14","doi-asserted-by":"crossref","unstructured":"Huanhuan, L. & Peng, S. The significance, trafficking and determination of labile iron in cytosol, mitochondria and lysosomes. Metallomics 10, 899\u2013916 (2018).","DOI":"10.1039\/C8MT00048D"},{"key":"25476_CR15","doi-asserted-by":"crossref","unstructured":"Dmitry, B., Magdalena, Z. & Steven, J. J. S. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909\u2013950 (2014).","DOI":"10.1152\/physrev.00026.2013"},{"key":"25476_CR16","doi-asserted-by":"crossref","unstructured":"Simran, S. & Paul, T. S. S. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel? Nat. Rev. Cancer 14, 709\u2013721 (2014).","DOI":"10.1038\/nrc3803"},{"key":"25476_CR17","doi-asserted-by":"crossref","unstructured":"Giuseppina, B. et al. Mitochondrial dysfunction in cancer and neurodegenerative diseases: spotlight on fatty acid oxidation and lipoperoxidation products. Antioxid. (Basel) 5, 7 (2016).","DOI":"10.3390\/antiox5010007"},{"key":"25476_CR18","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","volume":"79","author":"C Marlein","year":"2019","unstructured":"Marlein, C. et al. CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma. Cancer Res. 79, 2285\u20132297 (2019).","journal-title":"Cancer Res."},{"key":"25476_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lfs.2020.117971","volume":"256","author":"Y Xiang","year":"2020","unstructured":"Xiang, Y. et al. SR18292 exerts potent antitumor effects in multiple myeloma via Inhibition of oxidative phosphorylation. Life Sci. 256, 13 (2020).","journal-title":"Life Sci."},{"key":"25476_CR20","doi-asserted-by":"crossref","unstructured":"Tsvetkov, P. et al. vol 15, pg 681,. Mitochondrial metabolism promotes adaptation to proteotoxic stress Nat. Chem. Biol. 15, 757\u2013757 (2019). (2019).","DOI":"10.1038\/s41589-019-0315-5"},{"key":"25476_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"25476_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s43630-023-00361-0","volume":"22","author":"Y Wen","year":"2023","unstructured":"Wen, Y. et al. RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism. Photochemical Photobiological Sciences: Official J. Eur. Photochem. Association Eur. Soc. Photobiology. 22, 905\u2013917 (2023).","journal-title":"Photochemical Photobiological Sciences: Official J. Eur. Photochem. Association Eur. Soc. Photobiology"},{"key":"25476_CR23","first-page":"e13732","volume":"93","author":"X Lang","year":"2022","unstructured":"Lang, X. et al. RNA-Seq reveals the functional specificity of epididymal caput, corpus, and cauda genes of Cattleyak. Anim. Sci. J. = Nihon Chikusan Gakkaiho. 93, e13732 (2022).","journal-title":"Anim. Sci. J. = Nihon Chikusan Gakkaiho"},{"key":"25476_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41576-019-0150-2","volume":"20","author":"R Stark","year":"2019","unstructured":"Stark, R., Grzelak, M. & Hadfield, J. RNA sequencing: the teenage years. Nat. Rev. Genet. 20, 631\u2013656 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"25476_CR25","doi-asserted-by":"publisher","first-page":"e70215","DOI":"10.1111\/jcmm.70215","volume":"28","author":"T Jakobsen","year":"2024","unstructured":"Jakobsen, T. et al. The prognostic potential of circrnas in multiple myeloma: insights from whole bone marrow and purified plasma cells. J. Cell. Mol. Med. 28, e70215 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"25476_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. <i\u2009>\u2009limma powers differential expression analyses for RNA-sequencing and microarray studies<\/i\u2009>. Nucleic Acids Res. 43, 13 (2015).","journal-title":"Nucleic Acids Res."},{"key":"25476_CR27","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. <i\u2009>\u2009ggtranscript: an R package for the visualization and interpretation of transcript isoforms using\u2009<\u2009i\u2009>\u2009ggplot2<\/i\u2009>. Bioinformatics 38, 3844\u20133846 (2022).","journal-title":"Bioinformatics"},{"key":"25476_CR28","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"ZG Gu","year":"2016","unstructured":"Gu, Z. G., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"25476_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14, 15 (2013).","journal-title":"BMC Bioinform."},{"key":"25476_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jso.27358","volume":"128","author":"JH Lei","year":"2023","unstructured":"Lei, J. H. et al. Clinicopathological characteristics of pheochromocytoma\/paraganglioma and screening of prognostic markers. J. Surg. Oncol. 128, 510\u2013518 (2023).","journal-title":"J. Surg. Oncol."},{"key":"25476_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 38 (2014).","journal-title":"Genome Biol."},{"key":"25476_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcvm.2022.906753","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y. et al. Ferroptosis and autophagy-related genes in the pathogenesis of ischemic cardiomyopathy. Front. Cardiovasc. Med. 9, 16 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"25476_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"GC Yu","year":"2012","unstructured":"Yu, G. C., Wang, L. G., Han, Y. Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"25476_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"25476_CR35","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"25476_CR36","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"25476_CR37","doi-asserted-by":"crossref","unstructured":"Liu, P., Xu, H. C., Shi, Y. C., Deng, L. & Chen, X. Y. Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology. Evid.-based Complement Altern. Med. 20 (2020). (2020).","DOI":"10.1155\/2020\/3023127"},{"key":"25476_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41598-021-03995-1","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y., Lu, F. G. & Yin, Y. N. Applying logistic LASSO regression for the diagnosis of atypical crohn\u2019s disease. Sci. Rep. 12, 9 (2022).","journal-title":"Sci. Rep."},{"key":"25476_CR39","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y., Lu, F. & Yin, Y. Applying logistic LASSO regression for the diagnosis of atypical crohn\u2019s disease. Sci. Rep. 12, 11340 (2022).","journal-title":"Sci. Rep."},{"key":"25476_CR40","doi-asserted-by":"crossref","unstructured":"Ian, S. R. et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res. Cogn. 11, 1\u20135 (2017).","DOI":"10.1016\/j.scog.2017.10.001"},{"key":"25476_CR41","doi-asserted-by":"crossref","unstructured":"P J, H., T, L. & M S, P. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56, 337\u2013344 (2000).","DOI":"10.1111\/j.0006-341X.2000.00337.x"},{"key":"25476_CR42","first-page":"4068","volume":"13","author":"X Pan","year":"2021","unstructured":"Pan, X., Jin, X., Wang, J., Hu, Q. & Dai, B. Placenta inflammation is closely associated with gestational diabetes mellitus. Am. J. Transl Res. 13, 4068\u20134079 (2021).","journal-title":"Am. J. Transl Res."},{"key":"25476_CR43","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2147\/JIR.S410140","volume":"16","author":"S Jiang","year":"2023","unstructured":"Jiang, S. et al. Significance of Immunogenic cell death-related prognostic gene signature in cervical cancer prognosis and anti-tumor immunity. J. Inflamm. Res. 16, 2189\u20132207 (2023).","journal-title":"J. Inflamm. Res."},{"key":"25476_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12, 453\u2013 (2015).","journal-title":"Nat. Methods"},{"key":"25476_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41598-021-03807-6","volume":"12","author":"ZH Lin","year":"2022","unstructured":"Lin, Z. H. et al. Necroptosis-related LncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas. Sci. Rep. 12, 14 (2022).","journal-title":"Sci. Rep."},{"key":"25476_CR46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41598-022-27243-2","volume":"13","author":"C Xu","year":"2023","unstructured":"Xu, C., Gao, M., Zhang, J. H. & Fu, Y. F. IL5RA as an Immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. Sci. Rep. 13, 12 (2023).","journal-title":"Sci. Rep."},{"key":"25476_CR47","doi-asserted-by":"crossref","unstructured":"Saidmamatov, O. et al. Translation and adaptation of the adult developmental coordination disorder\/dyspraxia checklist (ADC) into Asian Uzbekistan. Sports (Basel) 11, 135 (2023).","DOI":"10.3390\/sports11070135"},{"key":"25476_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher, P., Cox, N., Huang, R. S. & pRRophetic An R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 9, 3 (2014).","journal-title":"PLoS One"},{"key":"25476_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-023-04033-6","volume":"21","author":"JJ Chang","year":"2023","unstructured":"Chang, J. J. et al. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. J. Transl Med. 21, 24 (2023).","journal-title":"J. Transl Med."},{"key":"25476_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13045-020-00993-0","volume":"13","author":"K Beider","year":"2020","unstructured":"Beider, K. et al. Blocking of transient receptor potential vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response. J. Hematol. Oncol. 13, 20 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"25476_CR51","doi-asserted-by":"crossref","unstructured":"Yukari, O. & Sojin, S. Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology. Front. Immunol. 14, 1179456 (2023).","DOI":"10.3389\/fimmu.2023.1179456"},{"key":"25476_CR52","doi-asserted-by":"crossref","unstructured":"Mario, B. The role of GPR15 function in blood and vasculature. Int. J. Mol. Sci. 22, 10824 (2021).","DOI":"10.3390\/ijms221910824"},{"key":"25476_CR53","doi-asserted-by":"crossref","unstructured":"Yukari, O. & Sojin, S. Differential phosphorylation signals control endocytosis of GPR15. Mol. Biol. Cell. 28, 2267\u20132281 (2017).","DOI":"10.1091\/mbc.e16-09-0627"},{"key":"25476_CR54","doi-asserted-by":"crossref","unstructured":"Gayathri, S. et al. The Aryl hydrocarbon receptor regulates expression of mucosal trafficking receptor GPR15. Mucosal Immunol. 14, 852\u2013861 (2021).","DOI":"10.1038\/s41385-021-00390-x"},{"key":"25476_CR55","doi-asserted-by":"crossref","unstructured":"Cecilie, A. et al. GPR15(+) T cells are Th17 like, increased in smokers and associated with multiple sclerosis. J. Autoimmun. 97, 114\u2013121 (2018).","DOI":"10.1016\/j.jaut.2018.09.005"},{"key":"25476_CR56","doi-asserted-by":"crossref","unstructured":"Jingyi, G. et al. Mitochondria as multifaceted regulators of ferroptosis. Life Metab. 1, 134\u2013148 (2022).","DOI":"10.1093\/lifemeta\/loac035"},{"key":"25476_CR57","doi-asserted-by":"crossref","unstructured":"Yu\u2019e, L. et al. The diversified role of mitochondria in ferroptosis in cancer. Cell. Death Dis. 14, 519 (2023).","DOI":"10.1038\/s41419-023-06045-y"},{"key":"25476_CR58","doi-asserted-by":"crossref","unstructured":"Jessica, C., Andrea, D. & Christian, S. NLRP7: from inflammasome regulation to human disease. Immunology 163, 363\u2013376 (2021).","DOI":"10.1111\/imm.13372"},{"key":"25476_CR59","doi-asserted-by":"crossref","unstructured":"Bing, L. et al. NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer. J. Exp. Clin. Cancer Res. 40, 126 (2021).","DOI":"10.1186\/s13046-021-01920-y"},{"key":"25476_CR60","doi-asserted-by":"crossref","unstructured":"Xu, F., Wei, W. & Feifei, L. AH-6809 mediated regulation of lung adenocarcinoma metastasis through NLRP7 and prognostic analysis of key metastasis-related genes. Front. Pharmacol. 15, 1486265 (2024).","DOI":"10.3389\/fphar.2024.1486265"},{"key":"25476_CR61","doi-asserted-by":"crossref","unstructured":"Bibo, F. et al. Integrated assessment of the clinical and biological value of ferroptosis-related genes in multiple myeloma. Cancer Cell. Int. 22, 326 (2022).","DOI":"10.1186\/s12935-022-02742-4"},{"key":"25476_CR62","doi-asserted-by":"crossref","unstructured":"Quanqiang, W. et al. Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma. Front. Pharmacol. 14, 1203125 (2023).","DOI":"10.3389\/fphar.2023.1203125"},{"key":"25476_CR63","doi-asserted-by":"crossref","unstructured":"Xin, J. et al. Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell. Death Discov 10, 45 (2024).","DOI":"10.1038\/s41420-024-01825-7"},{"key":"25476_CR64","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.7150\/jca.98520","volume":"15","author":"YC Chien","year":"2024","unstructured":"Chien, Y. C. et al. Analysis of ZNF208 polymorphisms on the clinicopathologic characteristics of Asian patients with hepatocellular carcinoma. J. Cancer. 15, 5183\u20135190 (2024).","journal-title":"J. Cancer"},{"key":"25476_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ctm2.1065","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X. et al. Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. Clin. Transl Med. 12, 19 (2022).","journal-title":"Clin. Transl Med."},{"key":"25476_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard, F. et al. Multiple myeloma. Nat. Rev. Dis. Primers. 10, 21 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"25476_CR67","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41568-024-00755-x","volume":"24","author":"DMC dos Santos","year":"2024","unstructured":"dos Santos, D. M. C., Toenges, R., Bertamini, L., Alberge, J. B. & Ghobrial, I. M. New horizons in our Understanding of precursor multiple myeloma and early interception. Nat. Rev. Cancer. 24, 867\u2013886 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"25476_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V124.21.3.3","volume":"124","author":"LQ Wang","year":"2014","unstructured":"Wang, L. Q., Liu, Q., Li, H., Li, L. Z. & Wang, X. The establishment of bortezomib resistant myeloma cell line KM3\/BTZ and explore the resistance mechanism. Blood 124, 3 (2014).","journal-title":"Blood"},{"key":"25476_CR69","doi-asserted-by":"crossref","unstructured":"Yumin, W. et al. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal. Transduct. Target. Ther. 8, 449 (2023).","DOI":"10.1038\/s41392-023-01720-0"},{"key":"25476_CR70","unstructured":"Linna, Z. et al. Overexpression of PRDM13 inhibits glioma cells via Rho and GTP enzyme activation protein. Int. J. Mol. Med. 42, 966\u2013974 (2018)."},{"key":"25476_CR71","doi-asserted-by":"crossref","unstructured":"Lei, W. et al. PRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression. Cancer Med. 5, 2558\u20132566 (2016).","DOI":"10.1002\/cam4.846"},{"key":"25476_CR72","doi-asserted-by":"crossref","unstructured":"Weimin, Z. et al. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis. Apoptosis 29, 412\u2013423 (2023).","DOI":"10.1007\/s10495-023-01909-2"},{"key":"25476_CR73","doi-asserted-by":"crossref","unstructured":"Yangyi, Z. et al. TRIB3 Inhibition by Palbociclib sensitizes prostate cancer to ferroptosis via downregulating SOX2\/SLC7A11 expression. Cell. Death Discov 10, 425 (2024).","DOI":"10.1038\/s41420-024-02152-7"},{"key":"25476_CR74","doi-asserted-by":"crossref","unstructured":"Tatsuya, F. et al. Crim1(C140S) mutant mice reveal the importance of cysteine 140 in the internal region 1 of CRIM1 for its physiological functions. Mamm. Genome 30, 329\u2013338 (2019).","DOI":"10.1007\/s00335-019-09822-3"},{"key":"25476_CR75","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2174\/1568009614666140725094125","volume":"14","author":"H Zeng","year":"2014","unstructured":"Zeng, H. & Tang, L. CRIM1, the antagonist of BMPs, is a potential risk factor of cancer. Curr. Cancer Drug Targets. 14, 652\u2013658 (2014).","journal-title":"Curr. Cancer Drug Targets"},{"key":"25476_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-022-02460-x","volume":"22","author":"H Han","year":"2022","unstructured":"Han, H. et al. miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt\/\u03b2-catenin signaling. Cancer Cell. Int. 22, 16 (2022).","journal-title":"Cancer Cell. Int."},{"key":"25476_CR77","doi-asserted-by":"crossref","unstructured":"Wei, W. et al. Low CRIM1 levels predict poor prognosis in breast cancer patients. Front. Oncol. 12, 882328 (2022).","DOI":"10.3389\/fonc.2022.882328"},{"key":"25476_CR78","doi-asserted-by":"crossref","unstructured":"Lixia, L. et al. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression. J. Exp. Clin. Cancer Res. 43, 200 (2024).","DOI":"10.1186\/s13046-024-03116-6"},{"key":"25476_CR79","doi-asserted-by":"crossref","unstructured":"Muthulekha, S., Elena, V., James, M. & Ehsan, J. I. H. M. & James J, D. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. J. Hematol. Oncol. 15, 17 (2022).","DOI":"10.1186\/s13045-022-01234-2"},{"key":"25476_CR80","doi-asserted-by":"crossref","unstructured":"Barbara, M. et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature 580, 257\u2013262 (2020).","DOI":"10.1038\/s41586-020-2134-y"},{"key":"25476_CR81","unstructured":"X Y, C. et al. [Molecular mechanisms and relationship of M2-polarized macrophages with early response in multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi 38, 480\u2013486 (2017)."},{"key":"25476_CR82","doi-asserted-by":"crossref","unstructured":"Khatora, S., Kate, O., Peter, V. & Jacqueline, J. P. E, N. & Andrew C W, Z. Macrophages in multiple myeloma: key roles and therapeutic strategies. Cancer Metastasis Rev. 40, 273\u2013284 (2021).","DOI":"10.1007\/s10555-020-09943-1"},{"key":"25476_CR83","unstructured":"Q L, G. et al. [Infiltration of tumor associated macrophages in multiple myeloma and its clinical significance]. Zhonghua Xue Ye Xue Za Zhi 39, 122\u2013127 (2018)."},{"key":"25476_CR84","doi-asserted-by":"crossref","unstructured":"Miaomiao, S. et al. Synergistic effects of multiple myeloma cells and tumor-associated macrophages on vascular endothelial cells in vitro. Med. Oncol. 37, 99 (2020).","DOI":"10.1007\/s12032-020-01426-1"},{"key":"25476_CR85","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Distinct cellular mechanisms underlie chemotherapies and PD-L1 Blockade combinations in triple-negative breast cancer. Cancer cell. 43, 446\u2013463 (2025).","DOI":"10.1016\/j.ccell.2025.01.007"},{"key":"25476_CR86","doi-asserted-by":"crossref","unstructured":"Ignacio, I. et al. Gene expression analysis of the bone marrow microenvironment reveals distinct immunotypes in smoldering multiple myeloma associated to progression to symptomatic disease. Front. Immunol. 12, 792609 (2021).","DOI":"10.3389\/fimmu.2021.792609"},{"key":"25476_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-03904-2","volume":"21","author":"CM Jia","year":"2023","unstructured":"Jia, C. M. et al. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma (20, 537, 2022). J. Transl Med. 21, 1 (2023).","journal-title":"J. Transl Med."},{"key":"25476_CR88","doi-asserted-by":"publisher","first-page":"zcae032","DOI":"10.1093\/narcan\/zcae032","volume":"6","author":"P Fuentes","year":"2024","unstructured":"Fuentes, P., Pelletier, J. & Gentilella, A. Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR Cancer. 6, zcae032 (2024).","journal-title":"NAR Cancer"},{"key":"25476_CR89","first-page":"17","volume":"32","author":"KH Maclachlan","year":"2024","unstructured":"Maclachlan, K. H. et al. Targeting the ribosome to treat multiple myeloma. Mol. Ther. Oncol. 32, 17 (2024).","journal-title":"Mol. Ther. Oncol."},{"key":"25476_CR90","doi-asserted-by":"crossref","unstructured":"Heather, F., Michelle, K., Allyson, S. & Ya-Wei, Q. & Michaela R, R. Adipocytes and metabolism: contributions to multiple myeloma. J. Bone Oncol. 46, 100609 (2024).","DOI":"10.1016\/j.jbo.2024.100609"},{"key":"25476_CR91","doi-asserted-by":"crossref","unstructured":"Steven, F. et al. The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. Blood Adv. 7, 3485\u20133500 (2023).","DOI":"10.1182\/bloodadvances.2022008345"},{"key":"25476_CR92","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1182\/bloodadvances.2022008345","volume":"7","author":"S Findlay","year":"2023","unstructured":"Findlay, S. et al. The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. Blood Adv. 7, 3485\u20133500 (2023).","journal-title":"Blood Adv."},{"key":"25476_CR93","first-page":"15","volume":"12","author":"WX Li","year":"2022","unstructured":"Li, W. X. et al. Shikonin induces ferroptosis in multiple myelomavia GOT1-mediated ferritinophagy. Front. Oncol. 12, 15 (2022).","journal-title":"Front. Oncol."},{"key":"25476_CR94","unstructured":"Oxane, K., Ellen, N., Margarita, M. & Jozefa, W. G. Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells. J. Exp. Ther. Oncol. 9, 27\u201335 (2011)."},{"key":"25476_CR95","doi-asserted-by":"crossref","unstructured":"Scott, R. G. et al. Next generation sequencing-based validation of the revised international staging system for multiple myeloma: an analysis of the MMRF CoMMpass study. Clin. Lymphoma Myeloma Leuk. 19, 285\u2013289 (2019).","DOI":"10.1016\/j.clml.2019.01.003"},{"key":"25476_CR96","doi-asserted-by":"crossref","unstructured":"Can, K. et al. Genetic and epigenetic aberrations of SOX7 in newly diagnosed and relapsed multiple myeloma as well as related neoplasms. Curr. Issues Mol. Biol. 47, 244 (2025).","DOI":"10.3390\/cimb47040244"},{"key":"25476_CR97","doi-asserted-by":"crossref","unstructured":"Yashu, F. et al. Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers. Sci. Rep. 15, 22478 (2025).","DOI":"10.1038\/s41598-025-06376-0"},{"key":"25476_CR98","doi-asserted-by":"crossref","unstructured":"Marcin, S., Piotr, \u0141., Katarzyna, B. K., Grzegorz, M. & Aleksandra, B. Polymorphisms in necroptosis pathway genes: novel prognostic markers for multiple myeloma treatment outcomes. Int. J. Mol. Sci. 26, 5237 (2025).","DOI":"10.3390\/ijms26115237"},{"key":"25476_CR99","doi-asserted-by":"crossref","unstructured":"Hongxiu, L. et al. DNA damage repair (DDR) related prognostic risk model in multiple myeloma based on single-cell and bulk sequencing. DNA Repair. (Amst) 152, 103857 (2025).","DOI":"10.1016\/j.dnarep.2025.103857"},{"key":"25476_CR100","doi-asserted-by":"crossref","unstructured":"Linzhi, X. et al. A monocyte-driven prognostic model for multiple myeloma: multi-omics and machine learning insights. Blood Lymphat Cancer 15, 21\u201337 (2025).","DOI":"10.2147\/BLCTT.S517354"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25476-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:04:05Z","timestamp":1763993045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25476-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25476"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25476-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Nuclear Industry 416 Hospital (YJ-2024-056) which only covers the experimental portion. All procedures were in accordance with the World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects and the ethical standards of the institutional and\/or national research committee. All participants signed a written informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"41548"}}